Telmisartan to reduce insulin resistance in HIV-positive individuals on combination antiretroviral therapy: the TAILoR dose-ranging Phase II RCT. (2019)
Abstract
No abstract provided
Bibliographic Information
Publication URI: https://www.journalslibrary.nihr.ac.uk/eme/eme06060#/
Type: Journal Article/Review
Volume: 6
Parent Publication: NIHR Journals Library
Issue: 6